Tower Research Capital LLC (Trc) Ultragenyx Pharmaceutical Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 853 shares of RARE stock, worth $36,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
853
Previous 14,303
94.04%
Holding current value
$36,704
Previous $587,000
91.99%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding RARE
# of Institutions
326Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$428 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$241 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$220 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$179 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$132 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.01B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...